Sepsis-associated liver injury: Incidence, classification and the clinical significance

Hepatology Research

Volumn 43, Issue 3, 2013, Pages 255-266

  Kobashi, Haruhiko ^a   Toshimori, Junichi ^a   Yamamoto, Kazuhide ^b  

^a Japanese Red Cross Okayama Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cholestasis; Jaundice; Sepsis; Sepsis associated liver injury; Shock liver; Systemic inflammatory response syndrome

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT DISEASE; CHILD; CHOLESTASIS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FUNCTION TEST; GALLBLADDER DISEASE; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; JAUNDICE; LIVER ABSCESS; LIVER CANCER; LIVER FUNCTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SCHOOL CHILD; SEPSIS; SEX RATIO;

EID: 84874290585     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01069.x     Document Type: Article

References (21)

1. Levy MM, Fink MP, Marshall JC etal. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31: 1250-6.
2. Dellinger RP, Levy MM, Carlet JM etal. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
3. Garvin IP. Remarks of pneumonia biliosa. S Med Surg 1837; 1: 536-44.
4. Famularo G, De Simone C, Nicotra GC. Jaundice and the sepsis syndrome: a neglected link. Eur J Intern Med 2003; 14: 269-71.
5. Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res 2005; 32: 250-1.
6. Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002; 6: 1045-66.
7. Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29: S42-7.
8. Gitlin N. Bacterial and systemic infections. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Disease of the Liver. Philadelphia, PA: Lippincott-Raven publishers, 1999; 1549-53.
9. Fuchs M, Sanyal AJ. Sepsis and cholestasis. Clin Liver Dis 2008; 12: 151-72.
10. O'Reilly M, Newcomb DE, Remick D. Endotoxin, sepsis, and the primrose path. Shock 1999; 12: 411-20.
11. Zhang P, Xie M, Spitzer JA. Hepatic neutrophil sequestration in early sepsis: enhanced expression of adhesion molecules and phagocytic activity. Shock 1994; 2: 133-40.
12. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007; 45: 230-41.
13. Narita R, Murata M, Kihara Y etal. Sepsis presenting with severe jaundice. Am J Gastroenterol 2001; 96: 3214-15.
14. Fontana RJ, Seeff LB, Andrade RJ etal. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52: 730-42.
15. Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 574-85.
16. Moseley RH. Sepsis and cholestasis. Clin Liver Dis 2004; 8: 83-94.
17. Franson TR, Hierholzer JWJ, LaBrecque DR. Frequency and characteristics of hyperbilirubinemia insoociated with bacteremia. Rev Infect Dis 1985; 7: 1-9.
18. Bansal V, Schuchert VD. Jaundice in the intensive care unit. Surg Clin North Am 2006; 86: 1495-502.
19. Whitehead MW, Hainsworth I, Kingham JG. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 2001; 48: 409-13.
20. Boelhorst T, Urlus M, Doesburg W, Yap A, Goris R. Etiologic factors of jaundice in severely ill patients. J Hepatol 1988; 7: 111-17.
21. Maynaud ND, Bihari DJ, Neil Dalton R etal. Liver function and splanchnic ischemia in critically ill patients. Chest 1997; 111: 180-7.